Dynavax Technologies Corp. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
62.62 M |
Public Float |
61.1 M |
Dynavax Technologies Corp. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$2.54 |
Market Cap |
$259.61 M |
Shares Outstanding |
65.06 M |
Public Float |
62 M |
Address |
2929 Seventh Street Berkeley California 94710 United States |
Employees | - |
Website | http://www.dynavax.com |
Updated | 07/08/2019 |
Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the development and discovery of novel vaccines and immuno-oncology therapeutics. It focuses on leveraging the body's innate and adaptive immune responses through toll-like receptor stimulation. It offers products for vaccines, cancer immunotherapy, and immune-mediated diseases. |